Clinical Trial Update: Everolimus Aging Study [Phase 2]

View source ↗

Summary

Phase 2 trial update of everolimus for aging and insulin resistance, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging
• Insulin Resistance

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Aging, Insulin Resistance | Phase 2 | Status: ACTIVE_NOT_RECRUITING